NASDAQ$OMCL

Omnicell Inc. · Q1 2020 earnings

Q1 2020 earnings · · Investor relations

Briefing

Reported first quarter results with revenue up 13.4% year-over-year and GAAP net income per diluted share up 225.0% year-over-year.

Omnicell reported GAAP revenues of $229.7 million, a 13.4% increase from Q1 2019. GAAP net income was $11.3 million, or $0.26 per diluted share, compared to $3.3 million, or $0.08 per diluted share, in the first quarter of 2019. The company withdrew its previously issued full year 2020 financial guidance due to the uncertainty surrounding the COVID-19 pandemic.

  • GAAP and non-GAAP revenues of $229.7 million, up 13.4% year-over-year
  • GAAP net income per diluted share of $0.26, up 225.0% year-over-year
  • Non-GAAP net income per diluted share of $0.66, up 8.2% year-over-year
  • Launched a Rapid Response program to fast-track production and deployment of XT Series automated dispensing systems

Headline financials

Total Revenue

$230M

Previous: $203M+13.4%
EPS (adj)

$0.66

Previous: $0.61+8.2%
Non-GAAP gross margin

49.4%

No prior period
Capital Expenditures

-$3.17M

Previous: $4.98M-163.7%
Free Cash Flow

$8.14M

Previous: $3.28M+147.8%
Net Income

$11.3M

Previous: $3.28M+244.4%
Operating Income

$12.2M

Previous: $12.8M-4.8%
Gross Profit

$110M

Previous: $97.1M+12.9%
Cash & Equivalents

$104M

Previous: $77.2M+34.7%
Total Assets

$1.23B

Previous: $1.18B+4.6%
Stock-Based Comp

$10.7M

Previous: $8.41M+26.7%

Revenue & EPS history

Omnicell · Revenue · Quarterly

$230M

Q1 2020+13.4%vs Q1 2019
Beat estimate in 14 of 16 quarters(88%)
ActualEstimate

Revenue by segment

Omnicell · $170M total across 1 segment · Q1 2020

  • Product revenues
    $170M

Forward guidance

As a result of the uncertainty surrounding the COVID-19 pandemic, the Company withdraws its previously issued full year 2020 financial guidance that was provided on February 6, 2020, and is unable to provide second quarter or full year 2020 guidance at this time.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2020

Historical avgQ1 2020

+0.7%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+4.7%

Avg return

30 days after

55%

36 / 65 earnings

Positive

+34.3%

Q2 2024

Best reaction

-29.4%

Q3 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.2%+13.7%+18.8%
Q4 2025-16.3%-16.5%-11.5%
Q3 2025+13.4%+16.7%+23.5%
Q1 2025-16.0%-15.4%+1.2%
Q4 2024-11.2%-7.1%-16.7%
Q3 2024+21.2%+20.9%+16.1%
Q2 2024+34.3%+41.6%+52.3%
Q1 2024+10.9%+11.5%+19.9%
Q4 2023-15.6%-11.9%-12.0%
Q3 2023-14.9%-13.9%-5.5%
Q2 2023+2.3%+2.9%-10.0%
Q1 2023+8.9%+7.1%+18.6%
Q4 2022+7.9%+6.6%+6.4%
Q3 2022-29.4%-35.9%-33.4%
Q2 2022-2.1%-5.6%-10.6%
Q1 2022+1.2%+5.9%+4.7%
Q4 2021-9.6%-18.4%-11.5%
Q3 2021+2.2%+1.6%+1.5%
Q2 2021-1.1%+0.4%+7.1%
Q1 2021+1.8%-1.5%-2.4%
Q4 2020+7.0%+8.9%+6.5%
Q3 2020+2.3%+2.9%+27.0%
Q2 2020+9.1%+5.5%+2.7%
Q1 2020-6.1%-12.3%-0.5%
Q4 2019-1.4%+2.3%-4.5%
Q3 2019-3.7%-1.9%+7.4%
Q2 2019+6.7%+5.4%+0.6%
Q1 2019+0.7%+3.8%+4.7%
Q4 2018+17.9%+21.0%+28.0%
Q3 2018+6.1%+15.2%+18.8%
Q2 2018+13.7%+13.0%+29.5%
Q1 2018+1.6%-0.1%+5.3%
Q4 2017-6.2%-9.8%-12.9%
Q3 2017-6.4%-8.2%-7.6%
Q2 2017+12.5%+16.3%+12.1%
Q1 2017-3.2%-1.7%+0.0%
Q4 2016-0.7%+1.0%+4.5%
Q3 2016-6.3%-6.8%+3.2%
Q2 2016+6.8%+4.7%+3.4%
Q1 2016+3.9%
Q4 2015-1.0%
Q3 2015-10.5%
Q2 2015-8.8%
Q1 2015-2.6%
Q4 2014+5.3%
Q3 2014+9.7%
Q2 2014-3.9%
Q1 2014+0.4%
Q4 2013+8.9%
Q3 2013-1.4%
Q2 2013+8.7%
Q1 2013+7.6%
Q3 2010-1.3%
Q4 2012+13.4%
Q3 2012+12.2%
Q2 2012+0.9%
Q1 2011-0.3%
Q1 2012+4.8%
Q4 2011+2.6%
Q4 2009+2.6%
Q3 2011-0.7%
Q2 2010-16.9%
Q2 2011-16.9%
Q4 2010-16.9%
Q1 2010+7.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro